In a significant lift for GlaxoSmithKline’s new shingles vaccine, the CDC committee in charge of vaccination policy in the U.S. endorsed Shingrix over the older shot, Merck’s Zostavax. If confirmed, the decision will give the newly approved GSK product a
read moreRegeneron is expanding its biologics plant in Ireland again, with its newest addition involving another $100 million investment and the addition of 300 more jobs. More: Regeneron plunks down 0M more on Ireland plant, adding another 300 workers Source: fierce
read moreIndia-based API maker Vital Laboratories was slapped with a warning letter from the FDA over manufacturing and records issues at its Plant II located in Vapi, Gujarat. More: FDA slaps India API drugmaker Vital Labs with warning letter Source: fierce
read moreGlaxoSmithKline said Wednesday that it’s looking hard at Pfizer’s up-for-sale OTC unit—but that was bad news to analysts worried about the fate of the company’s dividend. More: GlaxoSmithKline eyes Pfizer's OTC unit. But will a buy imperil its dividend? Source:
read moreEven though drug pricing talk in Washington, D.C., has quieted somewhat, a group of lawmakers continue to beat the drum for reform. At a Wednesday press conference, the legislators introduced a familiar idea they say has broad backing, but passing
read moreGilead has presented promising Phase II results for its experimental NASH drug GS-0976, showing significant reductions in the build up of liver fat and a marker of fibrosis. More: Gilead presents promising data for NASH drug Source: News
read more© 1994 - 2026 B.M. Pharmaceuticals